Skip to main content

Health and Medicine

Biomarkers may offer autism clues

Jul. 31, 2012—A combination of biomarkers may reveal new clues about causes of and potential interventions for autism.

Read more


National type I diabetes prevention trial now an option for younger children

Jul. 31, 2012—A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old.

Read more


Study finds mutation in melanoma sensitive to drug

Jul. 26, 2012—An uncommon mutation of the BRAF gene in melanoma patients has been found to respond to a specific drug therapy, providing a rationale for routine screening and therapy in melanoma patients who harbor the BRAF L597 mutation.

Read more


On the hunt for bladder cancer factors

Jul. 26, 2012—A protein linked to aggressive bladder cancers could point to new strategies for treatment or prevention.

Read more


Proteins guard against cancer spread

Jul. 24, 2012—Targeting immune system proteins may keep prostate cancer from spreading to bone.

Read more


High consumption of vitamin E may lower liver cancer risk

Jul. 20, 2012—High consumption of vitamin E either from diet or vitamin supplements may lower the risk of liver cancer, according to a study published July 17 in the Journal of the National Cancer Institute. The study was conducted by investigators from the Shanghai Cancer Institute, Vanderbilt-Ingram Cancer Center and the National Cancer Institute. Vitamin E is...

Read more


VU to map gaps in physician coverage across nation

Jul. 19, 2012—Vanderbilt researchers have been selected to receive a national grant as part of a push to gauge the coming impact of the Affordable Care Act (ACA).

Read more


Study tracks medication-related problems after hospital discharge

Jul. 19, 2012—As more and better treatments are developed for heart disease, it is becoming more difficult to safely manage care as patients return home from the hospital. A new study led by Vanderbilt researchers highlights growing concern that the period after hospital discharge is a risky time, especially for cardiac patients.

Read more


Long antibodies better against HIV

Jul. 19, 2012—Understanding how antibodies with long “loops” form may be important for HIV vaccine development.

Read more


Insights for neuroscience drug discovery

Jul. 17, 2012—When discovering drugs for brain disorders, it’s important to test the candidates in multiple ways to avoid advancing those with restricted physiological effects.

Read more


Childhood cancer investigator lands ‘Lemonade Stand’ grant

Jul. 12, 2012—Chin Chiang, Ph.D., professor of Cell and Developmental Biology and member of the Vanderbilt-Ingram Cancer Center faculty, has been awarded a $200,000 grant to study an aggressive form of childhood cancer.

Read more


VU leading international trial of new stroke therapy

Jul. 12, 2012—Researchers at Vanderbilt University Medical Center are leading an international clinical trial to examine the functional benefits of a combined therapy to treat acute ischemic stroke.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more